{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:27:48Z","timestamp":1793212068059,"version":"4.5.0"},"reference-count":24,"publisher":"Centers for Disease Control MMWR Office","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Morb. Mortal. Wkly. Rep."],"DOI":"10.15585\/mmwr.mm7103a2","type":"journal-article","created":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T10:25:03Z","timestamp":1642674303000},"page":"80-84","source":"Crossref","is-referenced-by-count":251,"title":["Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged \u226519 Years: Recommendations of the Advisory Committee on Immunization Practices \u2014 United States, 2022"],"prefix":"10.15585","volume":"71","author":[{"given":"Tara C.","family":"Anderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina B.","family":"Masters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Shepersky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Leidner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille N.","family":"Kotton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen L.","family":"Dooling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6224","published-online":{"date-parts":[[2022,1,21]]},"reference":[{"key":"key-10.15585\/mmwr.mm7103a2-202201201026-R1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.15585\/mmwr.mm6703a5","article-title":"Recommendations of the Advisory Committee on Immunization Practices for use of herpes zoster vaccines.","volume":"67","author":"Dooling","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm7103a2-202201201026-R2","unstructured":"Food and Drug Administration. Shingrix [package insert], revised: 07\/2021. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2021. https:\/\/www.fda.gov\/media\/108597\/download"},{"key":"key-10.15585\/mmwr.mm7103a2-202201201026-R3","first-page":"1","article-title":"Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"57","author":"Harpaz","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.mm7103a2-202201201026-R4","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/j.1525-1497.2005.0150.x","article-title":"The incidence of herpes zoster in a United States administrative database.","volume":"20","author":"Insinga","year":"2005","journal-title":"J Gen Intern Med"},{"key":"key-10.15585\/mmwr.mm7103a2-202201201026-R5","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/cid\/ciy954","article-title":"The epidemiology of herpes zoster in the United States during the era of varicella and herpes zoster vaccines: changing patterns among older adults.","volume":"69","author":"Harpaz","year":"2019","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.mm7103a2-202201201026-R6","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1093\/cid\/ciz1090","article-title":"Herpes zoster risk in immunocompromised adults in the United States: a systematic review.","volume":"71","author":"McKay","year":"2020","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.mm7103a2-202201201026-R7","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1002\/art.39670","article-title":"Risk of herpes zoster in autoimmune and inflammatory diseases: implications for vaccination.","volume":"68","author":"Yun","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"key-10.15585\/mmwr.mm7103a2-202201201026-R8","unstructured":"Advisory Committee on Immunization Practices. Advisory Committee on Immunization Practices (ACIP): GRADE (grading of recommendations, assessment, development and evaluation). Atlanta, GA: US Department of Health and Human Services, CDC; 2019. https:\/\/www.cdc.gov\/vaccines\/acip\/recs\/index.html"},{"key":"key-10.15585\/mmwr.mm7103a2-202201201026-R9","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1182\/blood-2014-04-573048","article-title":"A phase 1\/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients.","volume":"124","author":"Stadtmauer","year":"2014","journal-title":"Blood"},{"key":"key-10.15585\/mmwr.mm7103a2-202201201026-R10","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1093\/infdis\/jiu606","article-title":"Safety and immunogenicity of an adjuvanted herpes zoster subunit candidate vaccine in HIV-infected adults: a phase 1\/2a randomized, placebo-controlled study.","volume":"211","author":"Berkowitz","year":"2015","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.mm7103a2-202201201026-R11","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1001\/jama.2019.9053","article-title":"Effect of recombinant zoster vaccine on incidence of herpes zoster after autologous stem cell transplantation: a randomized clinical trial.","volume":"322","author":"Bastidas","year":"2019","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.mm7103a2-202201201026-R12","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/S1473-3099(19)30163-X","article-title":"Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis.","volume":"19","author":"Dagnew","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"key-10.15585\/mmwr.mm7103a2-202201201026-R13","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1093\/rheumatology\/keaa424","article-title":"Efficacy and serious adverse events profile of the adjuvanted recombinant zoster vaccine in adults with pre-existing potential immune-mediated diseases: a pooled post hoc analysis on two parallel randomized trials.","volume":"60","author":"Dagnew","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"key-10.15585\/mmwr.mm7103a2-202201201026-R14","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1002\/cncr.31909","article-title":"Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in patients with solid tumors, vaccinated before or during chemotherapy: a randomized trial.","volume":"125","author":"Vink","year":"2019","journal-title":"Cancer"},{"key":"key-10.15585\/mmwr.mm7103a2-202201201026-R15","first-page":"181","article-title":"Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in chronically immunosuppressed adults following renal transplant: a phase 3, randomized clinical trial.","volume":"70","author":"Vink","year":"2020","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.mm7103a2-202201201026-R16","unstructured":"Advisory Committee on Immunization Practices. ACIP meeting information. Atlanta, GA: US Department of Health and Human Services, CDC; 2021. https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/index.html"},{"key":"key-10.15585\/mmwr.mm7103a2-202201201026-R17","unstructured":"Kroger A, Bahta L, Hunter P. General best practice guidelines for immunization. Best practices guidance of the Advisory Committee on Immunization Practices (ACIP). Atlanta, GA: US Department of Health and Human Services, CDC. Accessed January 18, 2022. https:\/\/www.cdc.gov\/vaccines\/hcp\/acip-recs\/general-recs\/downloads\/general-recs.pdf"},{"key":"key-10.15585\/mmwr.mm7103a2-202201201026-R18","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1093\/infdis\/jix481","article-title":"Immunogenicity and safety of an adjuvanted herpes zoster subunit vaccine co-administered with seasonal influenza vaccine in adults aged 50 years and older.","volume":"216","author":"Schwarz","year":"2017","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.mm7103a2-202201201026-R19","doi-asserted-by":"publisher","first-page":"4278","DOI":"10.1016\/j.vaccine.2018.05.110","article-title":"Immunogenicity and safety of the adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine in adults \u226550\u202fyears of age: a randomized trial.","volume":"36","author":"Mar\u00e9chal","year":"2018","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.mm7103a2-202201201026-R20","doi-asserted-by":"publisher","first-page":"5877","DOI":"10.1016\/j.vaccine.2019.08.001","article-title":"The adjuvanted recombinant zoster vaccine co-administered with a tetanus, diphtheria and pertussis vaccine in adults aged \u226550 years: a randomized trial.","volume":"37","author":"Strezova","year":"2019","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.mm7103a2-202201201026-R21","doi-asserted-by":"publisher","first-page":"S111","DOI":"10.1002\/jmv.10364","article-title":"Varicella in Americans from NHANES III: implications for control through routine immunization.","volume":"70","author":"Kilgore","year":"2003","journal-title":"J Med Virol"},{"key":"key-10.15585\/mmwr.mm7103a2-202201201026-R22","doi-asserted-by":"publisher","first-page":"e20182917","DOI":"10.1542\/peds.2018-2917","article-title":"Incidence of herpes zoster among children: 2003-2014.","volume":"144","author":"Weinmann","year":"2019","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.mm7103a2-202201201026-R23","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1056\/NEJM199111283252204","article-title":"The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group.","volume":"325","author":"Hardy","year":"1991","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.mm7103a2-202201201026-R24","first-page":"1","article-title":"Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"56","author":"Marin","year":"2007","journal-title":"MMWR Recomm Rep"}],"container-title":["MMWR. Morbidity and Mortality Weekly Report"],"original-title":[],"deposited":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T10:26:57Z","timestamp":1642674417000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/71\/wr\/mm7103a2.htm?s_cid=mm7103a2_w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,21]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,1,21]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.mm7103a2","relation":{},"ISSN":["0149-2195","1545-861X"],"issn-type":[{"value":"0149-2195","type":"print"},{"value":"1545-861X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,1,21]]},"published":{"date-parts":[[2022,1,21]]}}}